Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Infergen Gives Hepatitis C Patients An Extra ChanceW*USA 9(WUSA) -- Approximately 50 percent of chronic hepatitis C patients do not respond to their initial course of therapy, according to Bruce R. Bacon MD of ...See all stories on this topic »

Hepatitis C - More Treatment Options Announced by NICENews FireNICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. (Press ...See all stories on this topic »

News Fire

New Hepatits C Drug Twice As Effective In Clinical TrialsRTT News(RTTNews) - A new drug called boceprevir has reportedly doubled the cure rate for Hepatitis C in a clinical trial monitored by the Food and Drug ...See all stories on this topic »

RTT News

Extended Treatment with Hepatitis C Drug Proved Optimistic, Informs VertexTopNews United Kingdom (blog)Vertex Pharma Inc. on Tuesday informed that one of the studies depicted that extended treatment with hepatitis C drug candidate, telaprevir, ...See all stories on this topic »

TopNews United Kingdom (blog)

Tattooing Significantly Increases the Risk of Contracting Hep CAIDSmeds.com HIV/AIDS Treatment NewsGetting a tattoo can increase a person's risk for contracting hepatitis C virus (HCV) by nearly six times, according to a study published online July 31 in ...See all stories on this topic »

Highest Rates Of Hepatitis C Virus Transmission Found In EgyptMedical News Today (press release)The Arab Republic of Egypt has the highest rates of new hepatitis C virus (HCV) infection in the world, according to a new study published in the ...See all stories on this topic »

Inmate Dies in Solitary ConfinementWBKOThe Jefferson County Coroner Office says 34-year-old Czaga had a history of Hepatitis C and died of natural causes. After a July 26 arrest, ...See all stories on this topic »

Dang! This Drug Is Shining BrighterMotley FoolBy Orelli | More Articles Not only does adding Vertex Pharmaceuticals' (Nasdaq: VRTX) telaprevir onto the standard of care for hepatitis C increase ...See all stories on this topic »

Pomerantz Law Firm Investigates Claims on Behalf of Investors of SciClone ...MarketWatch (press release)... develops, and commercializes specialist-oriented drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, ...See all stories on this topic »